Lifetimes of Heavy-Flavour Hadrons -- Whence and Whither?

A theoretical treatment for the weak decays of heavy-flavour hadrons has been developed that is genuinely based on QCD. Its methodology as it applies to total lifetimes and the underlying theoretical issues are sketched. Predictions are compared with present data. One discrepancy emerges: the beauty baryon lifetime appears to be significantly shorter than expected. The ramifications of those findings are analyzed in detail.Comment: 15 pages, no figures, LATEX, two references added and new information concerning a lower charm content in B decays incorporate

The Schr\" odinger picture of the Dirac quantum mechanics on spatially flat Robertson-Walker backgrounds

The Schr\" odinger picture of the Dirac quantum mechanics is defined in charts with spatially flat Robertson-Walker metrics and Cartesian coordinates. The main observables of this picture are identified, including the interacting part of the Hamiltonian operator produced by the minimal coupling with the gravitational field. It is shown that in this approach new Dirac quantum modes on de Sitter spacetimes may be found analytically solving the Dirac equation.Comment: 6 pages 0 figure

The leader operators of the (d+1)(d+1)-dimensional relativistic rotating oscillators

The main pairs of leader operators of the quantum models of relativistic rotating oscillators in arbitrary dimensions are derived. To this end one exploits the fact that these models generate P\"{o}schl-Teller radial problems with remarkable properties of supersymmetry and shape invariance.Comment: 11 page

A Novel Approach of Virotherapy Based Hsf-1 Shrna in Cancer Eradication

Cancer is the second leading cause of death worldwide with continues rise mortality rate. Current cancer treatment modalities are still ineffective and associated with many side effects leading to robust research to find new specific target therapy. Heat shock factor (HSF)-1 is heat shock response mediator protein and act as transcription factor for HSP encoding gene. Many cancers have up-regulated HSP as a result of increase HSF-1 expression. Interestingly, inhibition of HSF-1 has no effect to normal cell, indicating HSF-1 as promises target therapy. RNAi is potential mechanism to block and down regulate HSF-1 which will affect many cellular processes in cancer cell. Combining RNAi base treatment with oncolityc viruses will boost the therapeutic effect of this novel treatment. Despite its potency, this modality still need further research in order to evaluate its efficacy and optimal doses to gain optimal result